Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AAP Presses FDA To Eliminate OTC Pediatric Combination Products

This article was originally published in The Tan Sheet

Executive Summary

The American Academy of Pediatrics wants FDA to eliminate OTC combination pediatric cough/cold products.
Advertisement

Related Content

Despite EC Switch Denial, Attorneys See Value In Non-Sponsor Petitions
Despite EC Switch Denial, Attorneys See Value In Non-Sponsor Petitions
Pediatric Acetaminophen Panel Debates Execution Of Dosing Changes
Pediatric Acetaminophen Panel Debates Execution Of Dosing Changes
Acetaminophen OTC Combos Are Not Out Of The Woods, Despite Panel Vote
U.K. To Move Kids’ Cough/Cold Drugs BTC, Redraws Age Recommendation
FDA Call For Pediatric Cough/Cold Input Signals New Rule Is A Long Way Off

Topics

Advertisement
UsernamePublicRestriction

Register

PS105076

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel